Net Income (Loss) Per Share (Tables)

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders for the years ended December 31, 2024, 2023, and 2022 (in thousands, except share and per share data):

	Year Ended December 31,
	2024		2023		2022
Basic EPS
Numerator:
Net income (loss)	$	1,579,776	$	356,711	$	(192,746)
Less:
Income attributable to options exercises by promissory notes	(1,508)		(1,412)		—
Income attributable to unvested early exercised options	(2)		(23)		—
Income attributable to common stock subject to share repurchase agreements	(1,207)		(334)		—
Net income (loss) attributable to common stockholders—Basic	$	1,577,059	$	354,942	$	(192,746)
Denominator:
Weighted-average shares used in computing net income (loss) per share—Basic	336,921,483		351,952,187		371,568,011
Net income (loss) per share attributable to common stockholders—Basic	$	4.68	$	1.01	$	(0.52)
Diluted EPS
Numerator:
Net income (loss)	$	1,579,776	$	356,711	$	(192,746)
Less:
Income attributable to options exercises by promissory notes	(1,461)		(1,371)		—
Income attributable to unvested early exercised options	(2)		(23)		—
Income attributable to common stock subject to share repurchase agreements	(1,169)		(324)		—
Net income (loss) attributable to common stockholders—Diluted	$	1,577,144	$	354,993	$	(192,746)
Denominator:
Weighted-average shares used in computing net income (loss) per share—Basic	336,921,483		351,952,187		371,568,011
Weighted-average dilutive share-based awards and warrants	10,886,072		10,637,059		—
Weighted-average shares used in computing net income (loss) per share—Diluted	347,807,555		362,589,246		371,568,011
Net income (loss) per share attributable to common stockholders—Diluted	$	4.53	$	0.98	$	(0.52)

Schedule of Antidilutive Potential Common Shares

The following table presents the forms of antidilutive potential common shares:

	As of December 31,
	2024	2023	2022
Stock options exercised for promissory notes	85,000	1,399,999	1,399,999
Early exercised stock options	—	3,147	99,372
Stock options	—	115,229	11,315,805
Unvested RSUs	2,034	3,340,992	15,616,743
ESPP	49,488	1,917	856,811
Total antidilutive potential common shares	136,522	4,861,284	29,288,730